Personalized mRNA vaccine plus Keytruda lowers melanoma recurrence risk in Phase 3 trial
A personalized mRNA vaccine plus Keytruda lowers melanoma recurrence risk, Amgen’s Imdelltra plus Imfinzi cuts the risk of death by 58% in small cell lung cancer, and U.S. measles cases reach 4,588.
Bundibugyo Ebola outbreak passes 9,300 cases, now the second-largest on record
The Bundibugyo Ebola outbreak passes 9,300 confirmed cases, U.S. measles cases reach 4,410 for 2026, and a software CEO is sentenced to 19 years in a $1 billion Medicare telemedicine fraud.
FTC and seven states seek contempt finding against Martin Shkreli
The FTC and seven states seek a contempt finding against Martin Shkreli, a study finds pharma-funded ties among FDA advisory committee patient reps, and safety concerns grow over Vykat XR.
CVS agrees to pay $315 million to settle federal opioid-dispensing case
CVS agrees to pay $315 million to settle a federal opioid-dispensing case, U.S. measles cases pass 4,000 as Pennsylvania reports another death, and the DEA moves to schedule concentrated kratom derivatives.
FDA flags four deaths in Newron’s evenamide schizophrenia program
A Cochrane review links drug-company gifts and meals to less appropriate prescribing, the FDA flags four deaths in Newron’s evenamide program, and U.S. measles cases pass 4,000.
Cochrane review ties drug-company gifts and marketing to worse prescribing
A Cochrane review ties drug-company gifts and marketing to worse prescribing, the Bundibugyo Ebola outbreak becomes the second-largest on record, and U.S. measles cases reach 4,080 for 2026.
Russia tells WHO no plague cases in Irkutsk as lab worker’s death goes unexplained
Russia tells WHO there are no plague cases in Irkutsk, New York declares a measles disaster emergency, and the FDA approves the first heart valve designed to grow with children.